Funded by Brigham and Women's Hospital/Boston Univerity/NIH.
Funding Years: 2010-2013.
In this continuation of the REVEAL Study, we will conduct a new randomized clinical trial to determine the psychological and health behavior changes associated with disclosing APOE genotype and 3-year Risk estimates to persons with mild memory problems. We will also create a new instrument that clinicians and researchers can use to reliably evaluate a patient's capacity to consent to genetic testing and examine long-term impact of genetic Risk assessment by following REVEAL Study patients 2-10 years following disclosure. For more information, visit NIH Reporter Link.
PI(s): J. Scott Roberts